Myxoma
Recent clinical, regulatory, research and industry developments relating to this disease.
What's happening now
An analyst briefing on current research, clinical, regulatory and industry activity surrounding this disease.
Clinical trials
The current development programme across all trial phases.
Research activity
Key research shaping understanding of this disease, combining the latest publications with the most influential evidence.
Major themes2
- Heart Neoplasms1
- Myxoma1
Leading journals1
- European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology1
Leading researchers8
- Afgriyuspita LS1
- Alkaff FF1
- Arnindita JN1
- Kurniawan RB1
- Milla C1
- Multazam CECZ1
- Oktaviono YH1
- Pasahari D1
Affiliations (unnormalised)6
- Cardiovascular Research and Innovation Center1
- National Heart and Lung Institute1
- Universitas Airlangga1
- Universitas Airlangga - General Academic Hospital Dr. Soetomo1
- Universitas Airlangga - Universitas Airlangga Hospital1
- University Medical Center Groningen1
Reference
Authoritative identity, definition & identifiers.
A benign neoplasm derived from connective tissue, consisting chiefly of polyhedral and stellate cells that are loosely embedded in a soft mucoid matrix, thereby resembling primitive mesenchymal tissue. It occurs frequently intramuscularly where it may be mistaken for a sarcoma. It appears also in the jaws and the skin. (From Stedman, 25th ed)
- Disease identity & definition — NLM Medical Subject Headings (MeSH), public domain
- Clinical trials — ClinicalTrials.gov (U.S. National Library of Medicine)
- Research activity — Europe PMC (EMBL-EBI) + OpenAlex-derived paper links
- Related entities are derived from literature co-mention (studied together) — associative, not causal.